HUNTSMAN CANCER INSTITUTE became the first Mediso Preclinical Imaging Center of Excellence in North America.
Two multi-modality nanoScan in vivo preclinical imaging systems have been installed at HCI: a nanoScan PET/MRI, combining positron emission tomography and magnetic resonance imaging techniques in one integrated system, and a nanoScan SPECT/CT, combining single photon emission tomography and x-ray computed tomography in one combined system.
Both systems integrate four imaging modalities without any compromise in image quality, performance and ease of use.
HCI provides a unique combination with the possibility to perform quantitative preclinical imaging covering four modalities – PET, SPECT, MRI and CT.
The researchers are able to select any combination of the modalities to interrogate a wide range of biological questions by using the common building blocks developed by Mediso, including the Nucline acquisition framework and the MultiCell animal handling and monitoring system.
